June 14, 2007 — Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its BC-3200, an automatic three-part differential hematology analyzer, and Hypervisor VI, a central monitoring system.
The BC-3200 three-part differential hematology analyzer is the first automatic diagnostic laboratory instrument introduced by Mindray targeting the North American market. It is designed to provide reliable, efficient, and safe closed-tube sampling with a throughput rate of up to 60 samples per hour. The device is specifically targeted for cost-sensitive healthcare facilities and small laboratories as it delivers both more accurate test results and better overall performance than comparably priced devices.
The Hypervisor VI central monitoring system allows hospitals to benefit from powerful networking and patient data review capabilities. The system can connect up to 32 bedside patient monitors and allows healthcare professionals to view and manage data from each connected monitor and the hospital's record system at a central monitoring station.
For more information: www.mindray.com